Size and oxidative susceptibility of low-density lipoprotein particles in breast cancer patients with tamoxifen-induced fatty liver

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 8, 2002, Pages 3676-3681

  Wakatsuki, Akihiko ^a   Ogawa, Yasuhiro ^a   Saibara, Toshiji ^a   Okatani, Yuji ^a   Fukaya, Takao ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER SULFATE; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TAMOXIFEN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BREAST CANCER; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; FATTY LIVER; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; LIVER; PRIORITY JOURNAL; SPLEEN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036342383     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.8.8709     Document Type: Article

References (36)

1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy, 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
2. Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women
3. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
4. Induction of calcium-dependent nitric oxide synthesis by sex hormones
5. Reduced mortality associated with long-term postmenopausal estrogen therapy
6. Estrogen and cardiovascular function after menopause
7. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
8. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial
9. Should adjuvant tamoxifen therapy be stopped at 5 years?
10. Tamoxifen-induced fatty liver in patients with breast cancer
11. Antiatherogenic effects of adjuvant antiestrogens: A randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer
12. Change in LDL particle size is associated with changes in plasma triglyceride concentration
13. Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women
14. Estrogen-induced small low-density lipoprotein particles in postmenopausal women
15. Heterogeneity of serum low density lipoproteins in normal human subjects
16. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size
17. Enzymatic determination of total serum cholesterol
18. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human plasma
19. Automated immunoturbidimetric analysis of six plasma apolipoproteins: Correlation with radial immunodiffusion assays
20. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
21. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects
22. Protein measurement with the Folin phenol reagent
23. Continuous monitoring of in vitro oxidation of human low density lipoprotein
24. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
25. Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma
26. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17-α ethinyl estradiol
27. Tamoxifen decreases serum cholesterol by inhibiting cholesterol synthesis
28. Small low-density lipoprotein particles in women with natural or surgically induced menopause
29. Lipid transfer reactions and lipid composition of low-density lipoprotein particles in postmenopausal women receiving estrogen
30. Lipolytic enzyme effect on small low-density lipoprotein particles in women treated with estrogen
31. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men
32. Relationship of LDL size to insulin sensitivity in normoglycemic men
33. Estrogen-induced small low-density lipoprotein particles may be atherogenic in postmenopausal women
34. Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: A mechanism accounting for the cardioprotective action of tamoxifen?
35. Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women
36. Cirrhosis with steatohepatitis after adjuvant tamoxifen